Chris Nolet - Jan 25, 2024 Form 4 Insider Report for ArriVent Biopharma, Inc. (AVBP)

Role
Director
Signature
/s/ James Kastenmayer, Attorney-in-Fact for Chris Nolet
Stock symbol
AVBP
Transactions as of
Jan 25, 2024
Transactions value $
$0
Form type
4
Date filed
1/29/2024, 04:16 PM
Previous filing
Jun 8, 2023
Next filing
May 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVBP Stock Option (right to buy) Award $0 +17.9K $0.00 17.9K Jan 25, 2024 Common Stock 17.9K $18.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.